25
Participants
Start Date
November 21, 2019
Primary Completion Date
April 24, 2021
Study Completion Date
October 27, 2024
Valemetostat Tosylate
Once a day, 200 mg, oral administration
Nagoya City University Hospital, Nagoya
National Cancer Center Hospital East, Kashiwa-shi
Ehime University Hospital, Tōon-shi
Kyushu University Hospital, Fukuoka
National Hospital Organization Kyushu Cancer Center, Fukuoka
Hokkaido University Hospital, Sapporo
Imamura General Hospital, Kagoshima
Kochi Medical School Hospital, Nankoku-shi
Kumamoto University Hospital, Kumamoto
National University Corporation Tohoku University Tohoku University Hospital, Sendai
University of Miyazaki Hospital, Miyazaki
Local Incorporated Administrative Agency Sasebo City General Hospital, Sasebo-shi
Okayama University Hospital, Okayama
University of the Ryukyus Hospital, Nakagami-gun
Osaka International Cancer Institute, Osaka
Kindai University Hospital, Osakasayama-shi
Osaka University Hospital, Suita-shi
Saga University Hospital, Saga
Saitama Medical University International Medical Center, Hidaka-shi
Hamamatsu University Hospital, Hamamatsu
National Cancer Center Hospital, Chuo Ku
IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Minato-Ku
Kagoshima University Hospital, Kagoshima
Nagasaki University Hospital, Nagasaki
Lead Sponsor
Daiichi Sankyo Co., Ltd.
INDUSTRY